| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institutes of Pathology*
and
Radiobiology,
GSF-National Research
Center for Environment and Health, Neuherberg; the Institute of
Radiation Biology,
Ludwig Maximilian
University Munich, Munich; and the Institute of
Pathology§
and Department of
Surgery,¶
Technical University Munich,
Munich, Germany
To characterize cytogenetic alterations found in Barrett’s adenocarcinoma (BA) and, more importantly, its premalignant stages, we studied chromosomal imbalances in various lesions in the histologically proposed metaplasia-dysplasia-carcinoma sequence using comparative genomic hybridization (CGH). Using 30 esophageal adenocarcinoma resection specimens, we were able to study 30 areas of Barrett’s adenocarcinoma and 8 lymph node metastases (LN). In addition, we investigated 25 premalignant lesions adjacent to BA derived from a subset of 14 resection specimens including 11 areas of high grade dysplasia (HGD), 8 areas of low grade dysplasia (LGD), and 6 areas of intestinal metaplasia (IM), which were laser-microdissected and studied with CGH. To validate the CGH findings, fluorescence in situ hybridization analysis on 13 BA with probes specific for HER-2/neu and 20q13.2 were performed. The chromosomal alterations most often identified in BA were: gains on 8q (80%), 20q (60%), 2p, 7p and 10q (47% each), 6p (37%), 15q (33%) and 17q (30%). Losses were observed predominantly on the Y-chromosome (76%), 4q (50%), 5q and 9p (43% each), 18q (40%), 7q (33%) and 14q (30%). High-level amplifications were observed on 8q23-qter, 8p12-pter, 7p11-p14, 7q21–31, 17q11-q23. Recurrent chromosomal changes were also identified in metaplastic (gains on 8q, 6p, 10q, losses on 13q, Y, 9p) and dysplastic epithelium (gains on 8q, 20q, 2p, 10q, 15q, losses on Y, 5q, 9p, 13q, 18q). Novel amplified chromosomal regions on chromosomes 2p and 10q were detected in both Barrett’s adenocarcinoma and premalignant lesions. An increase of the average number of detected chromosomal imbalances from IM (7.0 ± 1.7), to LGD (10.8 ± 2.2), HGD (13.4 ± 1.1), BA (13.3 ± 1.4), and LN (22 ± 1.2) was seen. Although the detection of common chromosomal alterations in premalignant lesions and adjacent carcinomas suggest a process of clonal expansion, the occurrence of several chromosomal changes in an apparently random order relative to one another is striking evidence that clonal evolution is more complex than would be predicted by linear models. This is probably a reflection of the existence of many divergent neoplastic subpopulations and highlights one of the main problems associated with surveillance of Barrett’s patients, namely sampling error.
This article has been cited by other articles:
 |
|
 |
|
  T. G. Paulson, C. C. Maley, X. Li, H. Li, C. A. Sanchez, D. L. Chao, R. D. Odze, T. L. Vaughan, P. L. Blount, and B. J. Reid Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma Clin. Cancer Res., May 15, 2009; 15(10): 3305 - 3314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. I. Wistuba and M. Meyerson Chromosomal Deletions and Progression of Premalignant Lesions: Less Is More Cancer Prevention Research, November 1, 2008; 1(6): 404 - 408. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Rygiel, F. Milano, F. J. ten Kate, A. Schaap, K. K. Wang, M. P. Peppelenbosch, J. J.G.H.M. Bergman, and K. K. Krishnadath Gains and Amplifications of c-myc, EGFR, and 20.q13 Loci in the No Dysplasia-Dysplasia-Adenocarcinoma Sequence of Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1380 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Nancarrow, H. Y. Handoko, B. M. Smithers, D. C. Gotley, P. A. Drew, D. I. Watson, A. D. Clouston, N. K. Hayward, D. C. Whiteman, and for the Australian Cancer Study and the Study of D Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Res., June 1, 2008; 68(11): 4163 - 4172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Jin, A. Olaru, J. Yang, F. Sato, Y. Cheng, T. Kan, Y. Mori, C. Mantzur, B. Paun, J. P. Hamilton, et al. Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Clin. Cancer Res., November 1, 2007; 13(21): 6293 - 6300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C Fitzgerald Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, December 1, 2006; 55(12): 1810 - 1820. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Brankley, K. K. Wang, A. R. Harwood, D. V. Miller, M. S. Legator, L. S. Lutzke, B. R. Kipp, L. E. Morrison, and K. C. Halling The Development of a Fluorescence in Situ Hybridization Assay for the Detection of Dysplasia and Adenocarcinoma in Barrett's Esophagus J. Mol. Diagn., May 1, 2006; 8(2): 260 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Wongsurawat, J. C. Finley, P. C. Galipeau, C. A. Sanchez, C. C. Maley, X. Li, P. L. Blount, R. D. Odze, P. S. Rabinovitch, and B. J. Reid Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Helm, S. A. Enkemann, D. Coppola, J. S. Barthel, S. T. Kelley, and T. J. Yeatman Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal Adenocarcinoma Clin. Cancer Res., April 1, 2005; 11(7): 2478 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Unger, H. Zitzelsberger, G. Salvatore, M. Santoro, T. Bogdanova, H. Braselmann, P. Kastner, L. Zurnadzhy, N. Tronko, P. Hutzler, et al. Heterogeneity in the Distribution of RET/PTC Rearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4272 - 4279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Granelli, M. Cattaneo, S. Ferrero, L. Bottiglieri, S. Bosari, G. Fichera, and I. Biunno SEL1L and Squamous Cell Carcinoma of the Esophagus Clin. Cancer Res., September 1, 2004; 10(17): 5857 - 5861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.J.S. Jenkins, K. Harries, S.H. Doak, A. Wilmes, A.P. Griffiths, J.N. Baxter, and J.M. Parry The bile acid deoxycholic acid (DCA) at neutral pH activates NF-{kappa}B and induces IL-8 expression in oesophageal cells in vitro Carcinogenesis, March 1, 2004; 25(3): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Enzinger and R. J. Mayer Esophageal Cancer N. Engl. J. Med., December 4, 2003; 349(23): 2241 - 2252. [Full Text] [PDF]
|
|
|
|
|
|
C. T. Miller, J. R. Moy, L. Lin, M. Schipper, D. Normolle, D. E. Brenner, M. D. Iannettoni, M. B. Orringer, and D. G. Beer Gene Amplification in Esophageal Adenocarcinomas and Barrett's with High-Grade Dysplasia Clin. Cancer Res., October 15, 2003; 9(13): 4819 - 4825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S H Doak, G J S Jenkins, E M Parry, F R D'Souza, A P Griffiths, N Toffazal, V Shah, J N Baxter, and J M Parry Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus Gut, May 1, 2003; 52(5): 623 - 628. [Abstract] [Full Text]
|
|
|
|
|
|
C Tselepis, C D Morris, D Wakelin, R Hardy, I Perry, Q T Luong, E Harper, R Harrison, S E A Attwood, and J A Z Jankowski Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro Gut, February 1, 2003; 52(2): 174 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ling, A. Persson, B. Berne, M. Uhlen, J. Lundeberg, and F. Ponten Persistent p53 Mutations in Single Cells from Normal Human Skin Am. J. Pathol., October 1, 2001; 159(4): 1247 - 1253. [Abstract] [Full Text]
|
|
|
|
|
|
H. van Dekken, J. C. Alers, P. H. J. Riegman, C. Rosenberg, H. W. Tilanus, and K. Vissers Molecular Cytogenetic Evaluation of Gastric Cardia Adenocarcinoma and Precursor Lesions Am. J. Pathol., June 1, 2001; 158(6): 1961 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. J. Riegman, K. J. Vissers, J. C. Alers, E. Geelen, W. C. J. Hop, H. W. Tilanus, and H. van Dekken Genomic Alterations in Malignant Transformation of Barrett's Esophagus Cancer Res., April 1, 2001; 61(7): 3164 - 3170. [Abstract] [Full Text]
|
|
|
|
|
|
K. Specht, T. Richter, U. Muller, A. Walch, M. Werner, and H. Hofler Quantitative Gene Expression Analysis in Microdissected Archival Formalin-Fixed and Paraffin-Embedded Tumor Tissue Am. J. Pathol., February 1, 2001; 158(2): 419 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Walch, J. Mueller, H. Hofler, and M. Werner Re: Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue J Natl Cancer Inst, July 19, 2000; 92(14): 1182 - 1182. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
